NEWSÂ /Â Economy
BofA’s $250 Million-Plus Annual Bill for Employee Weight-Loss Meds Is a Test for Other Employers
Nate Gregory
Published Aug 5, 2026
[tts_player]
Share:
Summary:
- Bank of America spends more than $250 million a year covering GLP-1 weight-loss drugs for employees, part of a healthcare bill topping $2 billion.
- CEO Brian Moynihan pairs the drugs with health coaching and says the bank is aggressively negotiating prices with drugmakers and pharmacy benefit managers.
- Other employers are watching closely as per-patient costs climb into the thousands and some scale back coverage.
GLP-1 weight-loss drugs have gone from zero to everywhere in a few years. Bank of America just put a dollar figure on what “everywhere” costs
A Bill That Built Up Fast
Bank of America’s total healthcare spending is more than $2 billion a year
The drugs, sold under brand names like Ozempic and Wegovy, help people lose weight. The yearly cost per patient runs into the thousands of dollars
That is the math behind the GLP-1 boom. Huge demand and high per-patient costs have put employers across the country in a tough spot
The bank is the second-largest U.S. lender by assets. That size gives it real leverage when it negotiates with drugmakers and pharmacy benefit managers, the middlemen that decide which drugs get covered and at what price
Why the CEO Says It Is Worth the Money
He pointed to long-term health gains and possible short-term benefits, including fewer heart problems
“We see a great impact on the employees,” he said
Get the free Always Be Buying eBook and learn the simple system for building wealth on any income
The bank does not stop at the prescription. It pairs the drugs with health coaching to support weight loss and lifestyle changes, so employees have help building habits that last
“It’s been fascinating to watch our teammates’ behavior on these adjustments – the loss of weight,” Moynihan said
He also admitted the payoff is not guaranteed. Some employees will leave before the bank recovers its money, but offering strong benefits is the goal
The bank knows the result will not look like a typical investment. The return shows up slowly, and it is measured in healthier workers as much as in dollars
The Rest of the Country Is Watching
Moynihan made clear the bank is not accepting high prices without a fight. “Believe me, we’re pounding everybody on price,” he said
Bank of America uses its scale to negotiate lower prices with drugmakers and pharmacy benefit managers. That puts it in a different position from many other employers
Bank of America is going the other direction, at least for now
One of the biggest banks in the country is betting the drugs pay off. Many others are still deciding whether they can afford to
What the Bet Means for Your Health Care
The bottom line: When one of the country’s biggest banks says yes to these drugs and fights hard on the price, it shapes what other employers think is possible
The next few years will show whether the bet pays off. If healthier employees really do cost less over time, more companies may expand coverage
If the savings never show up, expect the opposite: tighter coverage and harder questions
For people who get insurance through work, the decisions matter. Your employer is watching this math just as closely as Bank of America is
The drugs may be a personal choice, but in many cases the bill is a workplace choice. And that bill is still growing
Download the free Always Be Buying eBook and start putting your money to work today
Disclosure
Trending Briefs
BofA CEO Warns AI Fund’s Near-Collapse Signals Market Risk
Aug 5, 2026
Amazon’s Zoox Robotaxis Start Charging Fares in Las Vegas
Aug 5, 2026
Iran and Oman Near Deal to Announce Hormuz Shipping Path
Aug 5, 2026
$100 Billion in Tariff Refunds Are Flowing Back to Importers
Aug 5, 2026
Kashkari Calls for Modest Fed Rate Hikes Starting Soon
Aug 5, 2026
BofA’s $250 Million-Plus Annual Bill for Employee Weight-Loss Meds Is a Test for Other Employers
Aug 5, 2026
PIF-Led Consortium Finalizes $55 Billion Purchase of Electronic Arts
Aug 5, 2026
SpaceX Stock Slips 7% as AI Investment Anxiety Builds
Aug 5, 2026
New US Restrictions on Chinese Optical Components May Threaten Cloud Giants
Aug 5, 2026
Trump’s Nuclear Battlefleet Could Carry a $275 Billion Price Tag, CBO Estimates
Aug 5, 2026
Get Market Briefs every morning for free!
No fluff. No noise. No politics. Just finance news in 5 minutes.
Subscribe Free
